Singapore markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.9200-0.0300 (-1.54%)
At close: 04:00PM EDT
1.9001 -0.02 (-1.04%)
After hours: 08:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
111,700
642,600
576,100
621,300
Total cash
111,700
642,600
576,100
621,300
Net receivables
141,800
102,700
230,500
172,700
Inventory
328,900
350,700
344,500
307,000
Other current assets
47,900
57,900
70,200
-
Total current assets
679,500
1,210,400
1,269,900
1,195,900
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
794,200
1,201,400
1,119,200
903,200
Accumulated depreciation
-411,400
-383,800
-319,100
-259,100
Net property, plant and equipment
382,800
817,600
800,100
644,100
Goodwill
0
218,200
224,900
266,700
Intangible assets
566,600
728,800
604,600
663,100
Other long-term assets
194,300
191,300
58,200
113,400
Total non-current assets
1,143,700
1,955,900
1,687,800
1,687,300
Total assets
1,823,200
3,166,300
2,957,700
2,883,200
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
413,700
957,300
31,600
33,800
Accounts payable
112,200
103,500
128,900
136,100
Accrued liabilities
18,600
34,900
51,700
46,900
Other current liabilities
32,700
45,900
73,100
83,100
Total current liabilities
651,300
1,228,900
374,000
384,500
Non-current liabilities
Long-term debt
446,500
448,500
809,400
841,000
Deferred tax liabilities
47,200
59,700
93,300
53,200
Deferred revenues
-
-
4,700
55,500
Other long-term liabilities
28,900
41,500
69,500
102,000
Total non-current liabilities
522,600
549,700
972,200
1,051,700
Total liabilities
1,173,900
1,778,600
1,346,200
1,436,200
Stockholders' equity
Common stock
100
100
100
100
Retained earnings
-21,800
738,700
950,300
726,900
Accumulated other comprehensive income
-5,700
3,100
-16,100
-25,300
Total stockholders' equity
649,300
1,387,700
1,611,500
1,447,000
Total liabilities and stockholders' equity
1,823,200
3,166,300
2,957,700
2,883,200